Comment
doi: 10.1016/S1473-3099(19)30523-7.
Epub 2019 Sep 25.
Can ceftolozane-tazobactam treat nosocomial pneumonia?
Affiliations
- PMID: 31563345
- DOI: 10.1016/S1473-3099(19)30523-7
Item in Clipboard
Comment
Can ceftolozane-tazobactam treat nosocomial pneumonia?
Lancet Infect Dis.
2019 Dec.
No abstract available
Comment on
-
Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial.Lancet Infect Dis. 2019 Dec;19(12):1299-1311. doi: 10.1016/S1473-3099(19)30403-7. Epub 2019 Sep 25. Lancet Infect Dis. 2019. PMID: 31563344 Clinical Trial.
Similar articles
-
Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012).Int J Antimicrob Agents. 2014 Jun;43(6):533-9. doi: 10.1016/j.ijantimicag.2014.01.032. Epub 2014 Mar 26. Int J Antimicrob Agents. 2014. PMID: 24856078
-
Doripenem for treating nosocomial pneumonia and ventilator-associated pneumonia.Lancet Infect Dis. 2020 Jan;20(1):20. doi: 10.1016/S1473-3099(19)30693-0. Lancet Infect Dis. 2020. PMID: 31876490 No abstract available.
-
Doripenem for treating nosocomial pneumonia and ventilator-associated pneumonia - Authors' reply.Lancet Infect Dis. 2020 Jan;20(1):20-21. doi: 10.1016/S1473-3099(19)30717-0. Lancet Infect Dis. 2020. PMID: 31876489 No abstract available.
-
Ceftolozane-tazobactam: A new-generation cephalosporin.Am J Health Syst Pharm. 2015 Dec 15;72(24):2135-46. doi: 10.2146/ajhp150049. Am J Health Syst Pharm. 2015. PMID: 26637512 Review.
-
Ceftolozane/Tazobactam: A New Cephalosporin and β-Lactamase Inhibitor Combination.Ann Pharmacother. 2015 Sep;49(9):1046-56. doi: 10.1177/1060028015593293. Epub 2015 Jul 9. Ann Pharmacother. 2015. PMID: 26160970 Review.
Cited by
-
New cephalosporins for the treatment of pneumonia in internal medicine wards.J Thorac Dis. 2020 Jul;12(7):3747-3763. doi: 10.21037/jtd-20-417. J Thorac Dis. 2020. PMID: 32802454 Free PMC article. Review.
-
Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infections.Intern Emerg Med. 2021 Nov;16(8):2231-2241. doi: 10.1007/s11739-021-02749-1. Epub 2021 May 6. Intern Emerg Med. 2021. PMID: 33956311 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
